A carregar...
Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
Approximately 25% of patients diagnosed with pancreatic cancer present with non-metastatic resectable or borderline resectable disease. Unfortunately, the cure rate for these “curable” patients is only in the range of 20%. Local-regional failure rates may exceed 50% after margin-negative, node-negat...
Na minha lista:
| Publicado no: | World J Gastrointest Surg |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783690/ https://ncbi.nlm.nih.gov/pubmed/31602289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v11.i7.303 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|